- Home
- TPR vs RPRX Comparison
TPR vs RPRX Comparison
Compare TPR & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPR | RPRX |
|---|---|---|
| Founded | 1941 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.4B | 22.0B |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TPR | RPRX |
|---|---|---|
| Price | $144.54 | $52.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 5 |
| Target Price | ★ $145.44 | $51.40 |
| AVG Volume (30 Days) | 2.1M | ★ 3.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | 1.13% | ★ 1.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.58 | 0.67 |
| Revenue | ★ $5,880,000,000.00 | $2,378,193,000.00 |
| Revenue This Year | $12.39 | $38.63 |
| Revenue Next Year | $5.36 | $4.73 |
| P/E Ratio | ★ $25.97 | $78.89 |
| Revenue Growth | ★ 31.01 | 5.06 |
| 52 Week Low | $84.39 | $34.63 |
| 52 Week High | $161.97 | $56.50 |
Technical Indicators
Market Signals| Indicator | TPR | RPRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 45.83 |
| Support Level | $136.82 | $35.33 |
| Resistance Level | $148.25 | $56.50 |
| Average True Range (ATR) | 5.15 | 1.42 |
| MACD | 0.58 | -0.40 |
| Stochastic Oscillator | 37.72 | 33.83 |
Price Performance
Historical ComparisonAbout TPR Tapestry Inc.
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 80% of its revenue and well over 90% of its operating profit in fiscal 2025. Handbags accounted for 58% of the brand's fiscal 2025 revenue. Coach products are sold through more than 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade (17% of fiscal 2025 revenue), which operates about 170 stores and generated 52% of its sales from handbags in fiscal 2025. Kate Spade is known for its colorful patterns and graphics. Tapestry sold its smallest brand, luxury footwear maker Stuart Weitzman, to Caleres in August 2025.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.